Recent Contributions of Single-cell and Spatial Profiling to the Understanding of Bladder Cancer

Overview

Journal Curr Opin Urol

Specialty Urology

Date 2024 Apr 23

PMID 38650456

Authors

Reinhard Grausenburger

Paula Herek

Shahrokh F Shariat

Bernhard Englinger

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Current risk stratification and treatment decision-making for bladder cancer informed by histopathology as well as molecular diagnostics face limitations. This review summarizes recent advancements in single-cell and spatial omics methodologies for understanding bladder cancer biology and their potential impact on development of novel therapeutic strategies.

Recent Findings: Single-cell RNA sequencing and spatial omics techniques offer unprecedented insights into various aspects of tumor microenvironment (TME), bladder cancer heterogeneity, cancer stemness, and cellular plasticity. Studies have identified multiple malignant cell subpopulations within tumors, revealing diverse transcriptional states and clonal evolution. Additionally, intratumor heterogeneity has been linked to tumor progression and therapeutic response. Immune cell composition analysis has revealed immunosuppressive features in the TME, impacting treatment response. Furthermore, studies have elucidated the role of cancer-associated fibroblasts and endothelial cells in shaping the tumor immune landscape and response to therapy.

Summary: Single-cell and spatial omics technologies have revolutionized our understanding of bladder cancer biology, uncovering previously unseen complexities. These methodologies provide valuable insights into tumor heterogeneity and microenvironmental interactions, with implications for therapeutic development. However, challenges remain in translating research findings into clinical practice and implementing personalized treatment strategies. Continued interdisciplinary collaboration and innovation are essential for overcoming these challenges and leveraging the full potential of single-cell and spatial omics in improving bladder cancer diagnosis and treatment.

References

Lee H, Chung W, Lee H, Jeong D, Jo A, Lim J . Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient. Genome Med. 2020; 12(1):47. PMC: 7251908. DOI: 10.1186/s13073-020-00741-6. View

Wang X, Pan L, Lu Q, Huang H, Feng C, Tao Y . A combination of ssGSEA and mass cytometry identifies immune microenvironment in muscle-invasive bladder cancer. J Clin Lab Anal. 2021; 35(5):e23754. PMC: 8128294. DOI: 10.1002/jcla.23754. View

Schallenberg S, Dragomir M, Anders P, Ebner B, Volz Y, Eismann L . Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis. Eur Urol Focus. 2023; 9(5):788-798. DOI: 10.1016/j.euf.2023.03.012. View

Zhou G, Qin G, Zhang Z, Zhao H, Xue L . Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma. Front Immunol. 2023; 14:1283792. PMC: 10637370. DOI: 10.3389/fimmu.2023.1283792. View

Meeks J, Al-Ahmadie H, Faltas B, Taylor 3rd J, Flaig T, DeGraff D . Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes. Nat Rev Urol. 2020; 17(5):259-270. PMC: 7968350. DOI: 10.1038/s41585-020-0304-1. View

Freshour S, Chen T, Fisk B, Shen H, Mosior M, Skidmore Z . Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer. iScience. 2023; 26(10):107937. PMC: 10558731. DOI: 10.1016/j.isci.2023.107937. View

Wang H, Mei Y, Luo C, Huang Q, Wang Z, Lu G . Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial-Mesenchymal Transition in Recurrent Bladder Cancer. Clin Cancer Res. 2021; 27(22):6265-6278. DOI: 10.1158/1078-0432.CCR-20-4796. View

Sirab N, Drubay D, Maille P, Popova T, Ngo C, Gentien D . Multilayer spectrum of intratumoral heterogeneity in basal bladder cancer. J Pathol. 2021; 256(1):108-118. DOI: 10.1002/path.5813. View

Lai H, Cheng X, Liu Q, Luo W, Liu M, Zhang M . Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. Int J Cancer. 2021; 149(12):2099-2115. DOI: 10.1002/ijc.33794. View

10.

Li T, Huang H, Shi G, Zhao L, Li T, Zhang Z . TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition. Cell Death Dis. 2018; 9(9):849. PMC: 6113209. DOI: 10.1038/s41419-018-0877-2. View

11.

Lindskrog S, Schmokel S, Nordentoft I, Lamy P, Knudsen M, Prip F . Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer. Eur Urol Open Sci. 2023; 51:78-88. PMC: 10175738. DOI: 10.1016/j.euros.2023.03.006. View

12.

Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y . Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020; 11(1):5077. PMC: 7545162. DOI: 10.1038/s41467-020-18916-5. View

13.

Zhang Q, Zhang W, Lin T, Lu W, He X, Ding Y . Mass cytometry reveals immune atlas of urothelial carcinoma. BMC Cancer. 2022; 22(1):677. PMC: 9210814. DOI: 10.1186/s12885-022-09788-7. View

14.

Lindskrog S, Prip F, Lamy P, Taber A, Groeneveld C, Birkenkamp-Demtroder K . An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Commun. 2021; 12(1):2301. PMC: 8052448. DOI: 10.1038/s41467-021-22465-w. View

15.

Li D, Feng D, Shi X, Wu R, Chen K, Han P . Identification of endothelial-related molecular subtypes for bladder cancer patients. Front Oncol. 2023; 13:1101055. PMC: 10070733. DOI: 10.3389/fonc.2023.1101055. View

16.

Ma Z, Li X, Mao Y, Wei C, Huang Z, Li G . Interferon-dependent SLC14A1 cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell. 2022; 40(12):1550-1565.e7. DOI: 10.1016/j.ccell.2022.11.005. View

17.

Kamoun A, De Reynies A, Allory Y, Sjodahl G, Robertson A, Seiler R . A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. 2019; 77(4):420-433. PMC: 7690647. DOI: 10.1016/j.eururo.2019.09.006. View

18.

Li Y, Xu X, Song L, Hou Y, Li Z, Tsang S . Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer. Gigascience. 2013; 1(1):12. PMC: 3626503. DOI: 10.1186/2047-217X-1-12. View

19.

Robertson A, Meghani K, Folgosa Cooley L, McLaughlin K, Fall L, Yu Y . Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer. Nat Commun. 2023; 14(1):2126. PMC: 10140274. DOI: 10.1038/s41467-023-37568-9. View

20.

Sfakianos J, Daza J, Hu Y, Anastos H, Bryant G, Bareja R . Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers. Nat Commun. 2020; 11(1):2540. PMC: 7242345. DOI: 10.1038/s41467-020-16162-3. View